Cargando…

Loss of Circulating CD8+ CD161(high) T Cells in Primary Progressive Multiple Sclerosis

Recent evidence suggests that the primary progressive form of multiple sclerosis (PP-MS) may present with specific immunological alterations. In this study we focused our attention on CD161, an NK and T cell marker upregulated in relapsing-remitting MS, and investigated its transcript and protein le...

Descripción completa

Detalles Bibliográficos
Autores principales:	Acquaviva, Massimo, Bassani, Claudia, Sarno, Nicole, Dalla Costa, Gloria, Romeo, Marzia, Sangalli, Francesca, Colombo, Bruno, Moiola, Lucia, Martinelli, Vittorio, Comi, Giancarlo, Farina, Cinthia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702304/ https://www.ncbi.nlm.nih.gov/pubmed/31474991 http://dx.doi.org/10.3389/fimmu.2019.01922

Ejemplares similares

Inferring Multiple Sclerosis Stages from the Blood Transcriptome via Machine Learning
por: Acquaviva, Massimo, et al.
Publicado: (2020)

Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis
por: Passerini, Gabriella, et al.
Publicado: (2016)

Myeloid cells as target of fingolimod action in multiple sclerosis
por: Di Dario, Marco, et al.
Publicado: (2015)

The Communication of Multiple Sclerosis Diagnosis: The Patients' Perspective
por: Messina, Maria Josè, et al.
Publicado: (2015)

Prognostic value of serum neurofilaments in patients with clinically isolated syndromes
por: Dalla Costa, Gloria, et al.
Publicado: (2019)

Dysregulation of MS risk genes and pathways at distinct stages of disease
por: Srinivasan, Sundararajan, et al.
Publicado: (2017)

Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing–Remitting Multiple Sclerosis Treated With Dimethylfumarate
por: Buscarinu, Maria C., et al.
Publicado: (2021)

Changes in cortical motor outputs after a motor relapse of multiple sclerosis
por: Chieffo, Raffaella, et al.
Publicado: (2019)

Percentages of CD4+CD161+ and CD4−CD8−CD161+ T Cells in the Synovial Fluid Are Correlated with Disease Activity in Rheumatoid Arthritis
por: Miao, Jinlin, et al.
Publicado: (2015)

CD161-Expressing Human T Cells
por: Fergusson, Joannah R., et al.
Publicado: (2011)

In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis
por: Vabanesi, Marco, et al.
Publicado: (2019)

Siponimod (BAF312) Activates Nrf2 While Hampering NFκB in Human Astrocytes, and Protects From Astrocyte-Induced Neurodegeneration
por: Colombo, Emanuela, et al.
Publicado: (2020)

Circulating CD3(+)CD4(+)CD161(+) Cells Are Associated with Early Complications after Autologous Stem Cell Transplantation in Multiple Myeloma
por: Lee, Sung-Eun, et al.
Publicado: (2018)

CD161+ regulatory t cells in immune regulation
por: Duurland, Chantal, et al.
Publicado: (2014)

Circulating CD4+CD161+ T Lymphocytes Are Increased in Seropositive Arthralgia Patients but Decreased in Patients with Newly Diagnosed Rheumatoid Arthritis
por: Chalan, Paulina, et al.
Publicado: (2013)

Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab
por: Diotti, Roberta Antonia, et al.
Publicado: (2016)

CD161(+) Tconv and CD161(+) Treg Share a Transcriptional and Functional Phenotype despite Limited Overlap in TCRβ Repertoire
por: Duurland, Chantal L., et al.
Publicado: (2017)

Human interleukin 17–producing cells originate from a CD161(+)CD4(+) T cell precursor
por: Cosmi, Lorenzo, et al.
Publicado: (2008)

Identification of Cytolytic CD161(−)CD56(+) Regulatory CD8 T Cells in Human Peripheral Blood
por: Hu, Dan, et al.
Publicado: (2013)

Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation
por: Kleinschek, Melanie A., et al.
Publicado: (2009)

Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis
por: Srinivasan, Sundararajan, et al.
Publicado: (2017)

CD8(+)CD161(+) T-Cells: Cytotoxic Memory Cells With High Therapeutic Potential
por: Konduri, Vanaja, et al.
Publicado: (2021)

Author Correction: Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis
por: Srinivasan, Sundararajan, et al.
Publicado: (2018)

Stress related to COVID-19 pandemic as a trigger for disease activity in multiple sclerosis: a case report
por: Giordano, Antonino, et al.
Publicado: (2021)

Laquinimod Modulates Human Astrocyte Function and Dampens Astrocyte-Induced Neurotoxicity during Inflammation
por: Colombo, Emanuela, et al.
Publicado: (2020)

LLT1-CD161 Interaction in Cancer: Promises and Challenges
por: Braud, Veronique M., et al.
Publicado: (2022)

Frequency of CD4+CD161+ T Cell and Interleukin-10 Expression in Inflammatory Bowel Diseases
por: Tsuchiya, Kazuyo, et al.
Publicado: (2017)

The identification and functional analysis of CD8+PD-1+CD161+ T cells in hepatocellular carcinoma
por: Li, Zhixuan, et al.
Publicado: (2020)

Cytotoxic CD161(−)CD8(+) T(EMRA) cells contribute to the pathogenesis of systemic lupus erythematosus
por: Xiong, Hui, et al.
Publicado: (2023)

Differential Effect of Cytomegalovirus Infection with Age on the Expression of CD57, CD300a, and CD161 on T-Cell Subpopulations
por: Hassouneh, Fakhri, et al.
Publicado: (2017)

Association Between Impaired Vα7.2+CD161++CD8+ (MAIT) and Vα7.2+CD161-CD8+ T-Cell Populations and Gut Dysbiosis in Chronically HIV- and/or HCV-Infected Patients
por: Merlini, Esther, et al.
Publicado: (2019)

Combining Clinical and Genetic Data to Predict Response to Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients: A Precision Medicine Approach
por: Ferrè, Laura, et al.
Publicado: (2023)

Expansion of mixed immune cells using CD3/CD161 co-stimulation for the treatment of cancer
por: Tsumura, Ryo, et al.
Publicado: (2023)

Impact of Aging on the Frequency, Phenotype, and Function of CD161-Expressing T Cells
por: van der Geest, Kornelis S. M., et al.
Publicado: (2018)

CD161 expression defines new human γδ T cell subsets
por: Karunathilaka, Amali, et al.
Publicado: (2022)

A CD4+CD161+ T-Cell Subset Present in Unexposed Humans, Not Tb Patients, Are Fast Acting Cells That Inhibit the Growth of Intracellular Mycobacteria Involving CD161 Pathway, Perforin, and IFN-γ/Autophagy
por: Yang, Rui, et al.
Publicado: (2021)

Tranilast, an analogue of tryptophan catabolites, induces allograft tolerance by CD161(+) cells
por: Ménoret, Séverine, et al.
Publicado: (2011)

Expression of Lectin-Like Transcript 1, the Ligand for CD161, in Rheumatoid Arthritis
por: Chalan, Paulina, et al.
Publicado: (2015)

CD161(int) CD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gut
por: Fergusson, J.R., et al.
Publicado: (2015)

The Clinical Relevance of IL-17-Producing CD4+CD161+ Cell and Its Subpopulations in Primary Sjögren's Syndrome
por: Li, Linbo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qi48isj5m5n5jhb7qsnhj9f99c